CNE000001JG2
CNE000001JG2
SHANGHAI SHYNDEC PHARMACEUTICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 11.41B EUR | 10.66B EUR | 14.23B EUR |
Enterprise Value | 6.99B EUR | 7.19B EUR | 10.54B EUR |
Valuation Multiples | |||
Trailing P/E | 20.76x | 14.67x | 14.96x |
Forward P/E | 8.26x | -- | -- |
Price to Sales | 1.35x | 1.23x | 1.52x |
Price to Book | 0.83x | 0.77x | 1.02x |
EV/Revenue | 0.83x | 0.83x | 1.12x |
EV/EBITDA | 5.14x | 5.99x | 6.87x |
Price to FCF (P/FCF) | 57.65x | 14.91x | 23.41x |
EV/FCF | 35.33x | 10.05x | 17.35x |
FCF Yield | 1.73% | 6.71% | 4.27% |